Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex (Q42759519)

6 November 2017

title

Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex. (English)

1 reference

Marcelo Nascimento Burattini

6 November 2017

1 reference

1 reference

4

object named as

Marcelo Nascimento Burattini

0 references

author name string

Adriana Lopes Motta

1

1 reference

6 November 2017

Gisele Madeira Duboc de Almeida

2

1 reference

6 November 2017

João Nóbrega de Almeida Júnior

3

1 reference

6 November 2017

Flávia Rossi

5

1 reference

6 November 2017

publication date

1 September 2010

1 reference

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

6 November 2017

published in

1 reference

6 November 2017

volume

14

1 reference

6 November 2017

issue

5

1 reference

6 November 2017

page(s)

441-448

1 reference

Epidemiology of invasive candidiasis: a persistent public health problem

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Candidemia in French hospitals: incidence rates and characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Clinical and microbiological aspects of candidemia due toCandida parapsilosisin Brazilian tertiary care hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare Workers

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Epidemiological trends in nosocomial candidemia in intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970091-X

7 January 2021

10.1016/S1413-8670(10)70091-X

Identifiers

DOI

1 reference

6 November 2017

1 reference